
Dr. Agarwal's Health Care IPO
- Issue price
- ₹402
- Listing price
- ₹402
- 0.00%
- Current price
- ₹550.8
- +37.01%
- Subscribed
- 1.49x
- Issue size
- ₹3,027.26 Cr
- Listed on
- 4 Feb 2025
IPO timeline
- Opens29 JanWed
- Closes31 JanFri
- Allotment3 FebMon
- Refunds4 FebTue
- Demat credit4 FebTue
- Listing4 FebTue
Issue details
- Price band
- ₹382 – ₹402 per share
- Issue size
- ₹3,027.26 Cr
- Fresh issue
- Not available
- Offer for sale
- Not available
- Issue type
- Fresh capital cum OFS
- Face value
- ₹1 per share
- Lot size
- 35 shares
- Minimum investment
- ₹14,070
- Listing on
- BSE, NSE
- Exchange code
- AGARWALEYE · 544350
This issue combines a fresh issue and an offer for sale. The amounts for each part are not available in our data; see the offer document for the split.
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 35 | ₹14,070 |
| Retail (Max) | 14 | 490 | ₹1,96,980 |
| S-HNI (Min) | 15 | 525 | ₹2,11,050 |
| B-HNI (Min) | 72 | 2,520 | ₹10,13,040 |
Reservation
- QIB
- 3,62,97,998 shares (50.00% of the Offer)
- NII
- 1,08,89,400 shares (15.00% of the Offer)
- Retail
- 2,54,08,599 shares (35.00% of the Offer)
- Employee
- 15,79,399 shares (2.10% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on KFin Technologies- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 3 Feb 2025
- Refunds initiated
- 4 Feb 2025
- Shares credited to demat
- 4 Feb 2025
- Listing
- 4 Feb 2025
Grey market premium (GMP)
- Current GMP
- ₹0
- 0.00%
- Estimated listing price
- ₹402
- Issue price ₹402
- Highest
- ₹140
- 23 Jan
- Lowest
- ₹0
- 3 Feb
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 3 Feb 2025 | ₹0 | 0.00% | ₹402 |
| 31 Jan 2025 | ₹1 | 0.00% | ₹403 |
| 30 Jan 2025 | ₹2 | 0.00% | ₹404 |
| 29 Jan 2025 | ₹8 | +2.00% | ₹410 |
| 27 Jan 2025 | ₹16 | +4.00% | ₹418 |
| 25 Jan 2025 | ₹40 | +10.00% | ₹442 |
| 24 Jan 2025 | ₹65 | +16.00% | ₹467 |
| 23 Jan 2025 | ₹140 | +35.00% | ₹542 |
- Kostak rate
- ₹0
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB4.41x
- NII (HNI)0.39x
- Retail0.42x
- Employee0.26x
- Shareholder0.51x
Financials
- P/E Ratio
- 160.48
- EPS (₹)
- 2.51
- RoE
- 9.33%
- RoCE
- 14.61%
- RoNW
- 6.21%
- PAT Margin
- 6.90%
- NAV (₹)
- 50.53
Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.
| Period ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 3,393.41 | 2,752.82 | 1,825.17 | 1,026.13 |
| Total Income | 837.94 | 1,376.45 | 1,031.49 | 713.78 |
| Profit After Tax | 39.56 | 95.05 | 103.23 | 43.16 |
| NET Worth | 1,502.67 | 1,337.68 | 627.83 | 212.34 |
| Reserves and Surplus | 1,509.11 | 1,365.86 | 652.63 | 236.27 |
| Total Borrowing | 373.68 | 387.79 | 356.18 | 290.18 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Health Care This IPO | ₹3,027.26 Cr | 160.48 | 6.21% | 6.90% | 1.49x | 0.00% |
| Emcure Pharmaceuticals Mainboard · listed 10 Jul 2024 | ₹1,952.03 Cr | 36.07 | 16.87% | 7.86% | 68.41x | +31.45% |
| Urban Company Mainboard · listed 17 Sep 2025 | ₹1,900 Cr | 61.68 | 13.35% | — | 108.96x | +57.52% |
| Allied Blenders & Distillers Mainboard · listed 2 Jul 2024 | ₹1,500 Cr | 1393.87 | 1.03% | 0.17% | 24.77x | +13.88% |
| Ola Electric Mobility Mainboard · listed 9 Aug 2024 | ₹6,145.56 Cr | -ve | -78.46% | — | 4.45x | 0.00% |
| DOMS Industries Mainboard · listed 20 Dec 2023 | ₹1,200 Cr | 32.43 | 28.39% | 2.51% | 98.51x | +77.22% |
| DAM Capital Advisors Mainboard · listed 27 Dec 2024 | ₹840.25 Cr | 28.37 | 44.98% | 38.75% | 81.88x | +38.87% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Dr. Agarwal's Health Care plans to use the money raised, as stated in the offer document.
- Repayment/prepayment, in part or full, of certain of the borrowings₹195 Cr
- General corporate purposes and Unidentified Inorganic Acquisitions₹77.47 Cr
- Issue Expenses₹140.69 Cr
About Dr. Agarwal's Health Care
Dr. Agarwal's Health Care Limited provides eye care services. The offering covers cataract, refractive and other surgeries, consultations and diagnoses. On 30 September 2024 it had 209 facilities, of which 193 were in India and 16 were across nine countries in Africa. The company uses a hub-and-spoke model, which lets larger centres support smaller ones. Growth has come from new centres and from acquisitions. The promoters include doctors from the Agarwal family and family trusts. Dr. Amar Agarwal and Dr. Athiya Agarwal are among the named promoters. The IPO was Rs 3,027.26 crore. Only Rs 300.00 crore was fresh issue and Rs 2,727.26 crore was offer for sale. Rs 195.00 crore of the proceeds was planned for repaying borrowings.
Strengths
- Total income rose from Rs 713.78 crore in FY2022 to Rs 1,031.49 crore in FY2023 and Rs 1,376.45 crore in FY2024.
- Net worth grew from Rs 212.34 crore on 31 March 2022 to Rs 1,502.67 crore on 30 September 2024.
- Total borrowing of Rs 373.68 crore on 30 September 2024 was well below net worth.
- Rs 195.00 crore of the fresh issue was planned for repaying part of those borrowings.
- The PAT margin was 6.90% and return on capital employed was 14.61%, as per the figures at the source.
Risks
- Rs 2,727.26 crore of the Rs 3,027.26 crore issue was offer for sale, so about nine tenths of the money went to selling shareholders.
- The P/E was 160.48 at the upper band of Rs 402, based on post-issue EPS of Rs 2.51.
- Profit after tax fell from Rs 103.23 crore in FY2023 to Rs 95.05 crore in FY2024 even though income rose.
- Profit after tax was Rs 39.56 crore in the six months to 30 September 2024 on total income of Rs 837.94 crore.
- Return on net worth was 6.21%, which is low against a P/E of 160.48.
- Total assets rose from Rs 1,825.17 crore on 31 March 2023 to Rs 3,393.41 crore on 30 September 2024, partly from acquisitions that must still pay back.
- Of the 193 facilities in India on 30 September 2024, 120 were in a few states led by Tamil Nadu and Maharashtra, so the business is regionally concentrated.
- Promoters held 37.72% before the issue and held 32.5% after it.
Promoters and shareholding
Amar Agarwal, Athiya Agarwal, Adil Agarwal, Anosh Agarwal, Ashvin Agarwal, Ashar Agarwal, Amar Agarwal Family Trust, Adil Agarwal Family Trust, Anosh Agarwal Family Trust, Ashvin Agarwal Family Trust, Ashar Agarwal Family Trust, DR.AGARWAL’S EYE INSTITUTE and Agarwal's Eye Institute Pvt.Ltd
- Promoter holding, pre-issue
- 37.72%
- Promoter holding, post-issue
- 32.5%
Anchor investors
Registrar, lead managers and documents
Lead managers
Dr. Agarwal's Health Care IPO: common questions
1.When does the Dr. Agarwal's Health Care IPO open and close?
The Dr. Agarwal's Health Care IPO opens on 29 Jan 2025 and closes on 31 Jan 2025.
2.What is the price band of the Dr. Agarwal's Health Care IPO?
The price band is ₹382 – ₹402 per share, with a lot size of 35 shares and a minimum investment of ₹14,070.
3.What is the size of the Dr. Agarwal's Health Care IPO?
The issue size is ₹3,027.26 Cr (Fresh capital cum OFS).
4.What is the GMP of the Dr. Agarwal's Health Care IPO?
The last reported grey market premium is ₹0 per share as of 03 Feb 2025, 12:00 PM IST. GMP is unofficial and changes frequently.
5.When is the Dr. Agarwal's Health Care IPO allotment?
The basis of allotment is expected on 3 Feb 2025. Allotment status can be checked with the registrar, KFin Technologies Limited.
6.When will the Dr. Agarwal's Health Care IPO list?
The shares listed on 4 Feb 2025 on BSE, NSE.
7.Who is the lead manager of the Dr. Agarwal's Health Care IPO?
The book running lead managers are Motilal Oswal Investment Advisors, Kotak Mahindra Capital Company Limited, Jefferies India Private Limited, Morgan Stanley India Co. Pvt. Ltd, and the registrar is KFin Technologies Limited.
8.What will the money raised in the Dr. Agarwal's Health Care IPO be used for?
As stated in the offer document, the proceeds are for: Repayment/prepayment, in part or full, of certain of the borrowings; General corporate purposes and Unidentified Inorganic Acquisitions; Issue Expenses.
9.How can my company launch an IPO like Dr. Agarwal's Health Care?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393